Cargando…

RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO

Detalles Bibliográficos
Autores principales:	FEDERBUSH, M., HASAN, Z., RODRIGUEZ, G., VARRONE, M., MUNDANCHIRA, G., MANETTA, F., NARASIMHAN, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Case-Based Discussion Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212619/ http://dx.doi.org/10.1016/j.chest.2022.04.036

Ejemplares similares

IDENTIFICATION OF RISK FACTORS PREDICTING MORTALITY IN PATIENTS WITH ARDS RELATED TO SEVERE COVID-19
por: SADIGOV, A.
Publicado: (2022)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

ECMO for Critically Ill COVID-19 with ARDS: A Case Series
por: Rai, D., et al.
Publicado: (2021)

Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

(591) Prolonged V.v.-Ecmo for Covid-19 Ards with Lung Recovery
por: Beckett, A., et al.
Publicado: (2023)

VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

To prone or not to prone ARDS patients on ECMO
por: Roca, Oriol, et al.
Publicado: (2021)

Ability of the respiratory ECMO survival prediction (RESP) score to predict survival for patients with COVID-19 ARDS and non-COVID-19 ARDS: a single-center retrospective study
por: Pratt, Elias H., et al.
Publicado: (2023)

Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
por: Prohaska, Stefanie, et al.
Publicado: (2018)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Tsolaki, Vasiliki, et al.
Publicado: (2021)

Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO
por: Textoris, Laura, et al.
Publicado: (2023)

Comparison of Respiratory and Hemodynamic Parameters of COVID-19 and Non-COVID-19 ARDS Patients
por: Asar, Sinan, et al.
Publicado: (2021)

ECMO, ARDS and AH1N1
por: Zangrillo, A
Publicado: (2009)

Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Bleakley, Caroline, et al.
Publicado: (2021)

Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy
por: Flinspach, Armin Niklas, et al.
Publicado: (2023)

ENTEROCOCCUS EMPYEMA FOLLOWING EXTRACORPEAL MEMBRANE OXYGENATION (ECMO) FOR COVID-19 ARDS: A CASE REPORT
por: GOERTZEN, STEPHEN M, et al.
Publicado: (2022)

ARDS RELATED TO COVID-19
por: Sekhon, Jasmine, et al.
Publicado: (2020)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies
por: Grieco, Domenico Luca, et al.
Publicado: (2020)

The advent of ECMO and pumpless extracorporeal lung assist in ARDS
por: Hamid, I A, et al.
Publicado: (2011)

ARDS from miliary tuberculosis successfully treated with ECMO
por: Vesteinsdottir, Edda, et al.
Publicado: (2019)

Successful repeat ECMO in a patient with AIDS and ARDS
por: Horikita, Sho, et al.
Publicado: (2017)

Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms
por: Desnos, Cyrielle, et al.
Publicado: (2020)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Transition from Simple V-V to V-A and Hybrid ECMO Configurations in COVID-19 ARDS
por: Suwalski, Piotr, et al.
Publicado: (2021)

Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

Acute respiratory failure in COVID-19: is it “typical” ARDS?
por: Li, Xu, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
por: Hoechter, D.J., et al.
Publicado: (2020)

Regional physiology of ARDS
por: Gattinoni, Luciano, et al.
Publicado: (2017)

Effect of prone positioning on oxygenation and static respiratory system compliance in COVID-19 ARDS vs. non-COVID ARDS
por: Park, Jimyung, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Lepper, Philipp M, et al.
Publicado: (2021)

Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
por: Friedrichson, Benjamin, et al.
Publicado: (2021)

Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort
por: Daviet, Florence, et al.
Publicado: (2021)

Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary
por: Patel, Sankalp P., et al.
Publicado: (2022)

A HIGH VOLUME, SINGLE CENTER STUDY OF VENO-VENOUS ECMO FOR COVID-19 ASSOCIATED SEVERE ARDS
por: Adams, Joseph, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qf7oj7gr1qpm2g2d1u52k6q1mf